You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperlipoproteinemia Type II

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A 12-week Post-marketing, Observational Study to Confirm Safety

Completed
  • Hypercholesterolemia
  • +2 more
  • Ezetimibe
  • Ezetimibe + other lipid-lowering medication(s)
  • (no location specified)
Feb 7, 2022

Familial Hypercholesterolemia - Heterozygous Trial in Paris (CAC Score)

Completed
  • Familial Hypercholesterolemia - Heterozygous
  • CAC Score
  • Paris, France
    Hôpital Pitié-Salpêtrière
Sep 9, 2021

Familial Hypercholesterolemia Trial in Xi'an (Low Density Lipoprotein Receptor mRNA Exosomes)

Not yet recruiting
  • Familial Hypercholesterolemia
  • Low Density Lipoprotein Receptor mRNA Exosomes
  • Xi'an, Shannxi, China
    Tangdu Hospital, Air Force Medical University
Sep 3, 2021

Method to Identify and Diagnose Familial Hypercholesterolemia

Enrolling by invitation
  • Familial Hypercholesterolemia
  • Hypercholesterolemia
    • Stockholm, Sweden
      Karolinska university hospital
    Sep 1, 2021

    Familial Hypercholesterolemia, Lipid Disorder Trial in Montreal

    Recruiting
    • Familial Hypercholesterolemia
    • Lipid Disorder
      • Montreal, Quebec, Canada
        Research Institute of the McGill University Health Centre: Glen
      Oct 8, 2021

      Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia Trial in Danville (Receive an

      Recruiting
      • Hereditary Breast and Ovarian Cancer Syndrome
      • +2 more
      • Receive an adult-onset result
      • +2 more
      • Danville, Pennsylvania
        Geisinger
      Feb 15, 2022

      Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia Trial (EZ 10 mg/Atorva 20 mg FDC, EZ 10 mg/Atorva 10 mg FDC)

      Completed
      Has Results
      • Hypercholesterolemia
      • Heterozygous Familial Hypercholesterolemia
      • EZ 10 mg/Atorva 20 mg FDC
      • EZ 10 mg/Atorva 10 mg FDC
      • (no location specified)
      Feb 7, 2022

      Familial Hypercholesterolemia, Nutrition, Healthy, Cholesterol, Elevated Trial in Québec (Canada's Food Guide principles (CFG

      Recruiting
      • Familial Hypercholesterolemia
      • +4 more
      • Canada's Food Guide principles (CFG diet)
      • Standard North American diet (NAD diet)
      • Québec, Canada
        Institute on nutrition and functional foods, Laval University
      Jan 10, 2022

      Familial Hypercholesterolemia Trial (FH diagnosis program, Implementation strategy package: Develop and implement tools for

      Not yet recruiting
      • Familial Hypercholesterolemia
      • FH diagnosis program
      • +7 more
      • (no location specified)
      Mar 8, 2022

      Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)

      Active, not recruiting
      • Heterozygous Familial Hypercholesterolemia
      • Cincinnati, Ohio
      • +6 more
      Nov 3, 2022

      Stemi Patient Who Underwent Ppci

      Active, not recruiting
      • Familial Hypercholesterolemia
      • Genetic
      • Assiut, Egypt
        Amira harby
      Jun 3, 2021

      Efficacy and Safety, Heterozygous Familial Hypercholesterolemia, PCSK9 Trial in Shenzhen (protein convertase subtilisin/kexin

      Active, not recruiting
      • Efficacy and Safety
      • +2 more
      • protein convertase subtilisin/kexin type 9 inhibitor
      • Shenzhen, Guangdong, China
        xili People's Hospital
      Aug 24, 2021

      Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

      Recruiting
      • Homozygous Familial Hypercholesterolemia
      • ARO-ANG 3 Injection
      • Mount Sinai, New York
      • +7 more
      Sep 26, 2022

      Familial Hypercholesterolaemia Trial in Czechia (Total cholesterol (TC) level test and direct Low density lipoprotein

      Recruiting
      • Familial Hypercholesterolaemia
      • Total cholesterol (TC) level test and direct Low density lipoprotein cholesterol (LDL-C) level test
      • DNA testing
      • Brno, Czechia
      • +10 more
      Nov 25, 2022

      Subclinical Atherosclerosis in Familial Hypercholesterolemia

      Recruiting
      • Hypercholesterolemia, Familial
      • Napoli, Italy
        Matteo Di Minno
      Mar 4, 2021

      Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

      Active, not recruiting
      • Lipoprotein Lipase Deficiency
      • +2 more
        • Rostock, Germany
        • +3 more
        May 12, 2021

        Familial Hypercholesterolemia - Homozygous, Lipid Metabolism Disorders, Proprotein Convertase Subtilisin/Kexin 9 Trial in

        Recruiting
        • Familial Hypercholesterolemia - Homozygous
        • +2 more
        • IBI306
        • Shenzhen, Guangdong, China
          xili People's Hospital
        Jun 29, 2021

        Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

        Active, not recruiting
        • Homozygous Familial Hypercholesterolemia
        • Evanston, Illinois
        • +11 more
        Jul 13, 2022

        Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Placebo)

        Recruiting
        • Dyslipidemias
        • +8 more
        • Sarasota, Florida
        • +11 more
        Aug 10, 2022

        Amlodipine/Atorvastatin Drug Use Investigation

        Completed
        Has Results
        • Hypertension
        • +3 more
        • (no location specified)
        Jan 26, 2021

        Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia Trial in Australia, New Zealand (ARO-ANG3, sterile normal

        Completed
        • Dyslipidemias
        • +2 more
        • Camperdown, New South Wales, Australia
        • +5 more
        Sep 20, 2021

        Familial Hypercholesterolemia Trial in New York (Evolocumab)

        Terminated
        Has Results
        • Familial Hypercholesterolemia
        • New York, New York
          Columbia University Medical Center
        Mar 5, 2021

        Heterozygous Familial Hypercholesterolemia Trial in Beijing (IBI306, )

        Active, not recruiting
        • Heterozygous Familial Hypercholesterolemia
        • Beijing, China
          Beijing Anzhen Hospital， Capital Medical University
        Jan 27, 2021

        Hypercholesterolemia, Familial Trial in Philadelphia, Amsterdam (Kinetics test)

        Completed
        • Hypercholesterolemia, Familial
        • Kinetics test
        • Philadelphia, Pennsylvania
        • +1 more
        May 14, 2021

        Homozygous Familial Hypercholesterolaemia (HoFH) Trial in Worldwide (Lomitapide)

        Recruiting
        • Homozygous Familial Hypercholesterolaemia (HoFH)
        • Heidelberg, Baden-Wurttemberg, Germany
        • +13 more
        Apr 4, 2022